EClinicalMedicine April 2021 PMID 33875978

Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019.

Sylvia Ranjeva, Riccardo Pinciroli, Evan Hodell, Ariel Mueller, C Corey Hardin, B Taylor Thompson, Lorenzo Berra

Download social card

Mentions

Peak: 6 in Apr 2021

across 4 sources since Apr 2021

Extended reach

22,850

potential audience

Total likes

Video views

2,388

Mentions per month

Apr 2021

All 6 dated mentions so far are from Apr 2021.

Where it's discussed

News14 articles
X / Twitter4 posts
YouTube2 videos
Facebook2 posts

AI synopsis

What people are saying

The discussions focus on recognizing the significance of differentiating COVID-19 ARDS phenotypes, with posts referencing the study's findings on blood clotting and organ damage. The tone remains neutral and fact-based, emphasizing the publication’s potential to inform future treatment strategies without expressing strong opinions or critiques.

AgreementModerate agreement

Most discussions acknowledge the importance of identifying phenotypes in COVID-19 ARDS, showing general support.

InterestModerate interest

Participants seem moderately interested, as they highlight key aspects but do not delve deeply into methodological details.

EngagementModerate engagement

The posts indicate a basic level of involvement, mainly sharing the publication title and brief reactions rather than critical analysis.

ImpactModerate impact

The discussions suggest some recognition of the potential implications for treatment, though comments are mostly exploratory and not highly influential.

Abstract in brief

The study identified two distinct clinical and biochemical phenotypes in COVID-19 related ARDS patients, with one phenotype showing increased markers of blood clotting problems and organ damage.
Despite similar respiratory difficulties, the two groups differed significantly in systemic health indicators and risk of death, with the more severe group having more than double the mortality rate.
These findings suggest that COVID-19 ARDS has unique biological subtypes that could influence treatment strategies, especially focusing on clotting and vascular issues in severe cases.]

Read the full abstract

All mentions

COVID-19 ARDS Phenotypes Impacting Mortality and Treatment Strategies

The chances of survival for COVID-19 patients with acute respiratory distress syndrome depend on more than lung function. Systemic inflammation, organ failure, and blood clotting issues can double the risk of death…

Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V. · Apr 26, 2021 1,884 views

COVID-19 ARDS Phenotypes and Their Impact on Mortality Rates

COVID-19 patients with ARDS have varying survival chances that depend on more than lung function alone. Systemic inflammation, organ failure, and blood clotting issues can double the risk of death, highlighting the…

Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin (DGIIN) · Apr 25, 2021 504 views

Edinburgh Watch

@EdinburghWatch · X

RT @troponinpapers: Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease…

Apr 20, 2021 · 1 share · 12,034 followers View post →

Troponin_papers

@troponinpapers · X

Identifying clinical and biochemical phenotypes in acute respiratory distress syndrome secondary to coronavirus disease-2019 https://t.co/h0HVFTRjtz https://t.co/uhWGEALWww

Apr 20, 2021 · 1 share · 498 followers View post →

NFTdose

@PaperbirdsH · X

Apr 20, 2021 · 302 followers View post →

eClinicalMedicine – The Lancet Discovery Science

@eClinicalMed · X

Apr 16, 2021 · 7,624 followers View post →